More than 90 Million Global Merchants Leverage Alipay+ Payment and Digitalisation Solutions to Attract and Engage Travellers this Chinese New Year
28.1.2025 07:37:00 CET | Business Wire | Press release
Alipay+ has extensive merchant acceptance in travel hotspots like South Korea, Japan, Malaysia, Singapore and China, through its partnerships with standardised QR operators, from street vendors to attractions and shopping mallsAlipay+ connects leading Asian e-wallets to top travel platforms like AirAsia MOVE and Booking.com, simplifying overall travel booking processMerchants also tap on Alipay+ solutions for in-app destination marketing and mini-program development to enhance travel experience; Geneva Tourism Bureau uses Alipay+ solution to launch in-app travel hub
As global tourism transitions from a year of recovery to a year of growth in 2025, global merchants tap on Alipay+, Ant International’s cross-border mobile payment and digitalisation solutions, to enhance payments, in-app marketing and digital services development, to attract and welcome tourists for Chinese New Year, the first travel peak of the year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250127889352/en/
Alipay+ and partners launch exclusive campaigns for Chinese New Year (Photo: Business Wire)
Alipay+ supports over 35 international wallet and bank payment partners, connecting their 1.6 billion user accounts to more than 90 million merchants in 66 markets. Alipay+ recently enabled acceptance for new partners, including Kaspi.kz (Kazakhstan) and BigPay (Malaysia, Singapore and Thailand), connecting even more users to its global merchants.
Alipay+ partners with global merchants to launch exclusive Chinese New Year campaigns to excite travellers
Around the world, Alipay+ and its merchant partners are jointly introducing promotions for Alipay+ payment partner users, in anticipation of the seasonal travel surge. Together with Alipay+, leading retailers like Resorts World Sentosa, Marina Bay Sands, Central Retail, King Power, Pavilion KL, Lotte World, Olive Young, Daimaru, Printemps, Galleries Lafayette and airport duty free stores with more than one hundred thousand stores are driving in-store and in-app engagement with upsized rewards.
- China: Travellers can use Alipay and 13 international payment apps to make convenient, seamless payments. Users of AlipayHK, Mpay, Touch ‘n Go eWallet, TrueMoney and GCash, can access promotional packs in over 100 Consumer Friendly Zones in top cities like Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu and more, with merchant spotlights and special discounts. The International Consumer Friendly Zones program expands bilingual support, offers user guides and bolsters merchant training to provide a more welcoming experience for travellers.
- South Korea: Alipay+ is accepted at over 2 million merchants, including all merchants who accept ZeroPay. Users can enjoy tiered discounts at selected merchants, and in Seoul, users can also expect additional benefits including at Lotte World and select stores in the Myeongdong, Dongdaemun and Seongsu districts. To facilitate ease of travel, the NAMANE x Alipay+ Transit Pass Card was recently launched for nationwide use on buses and subways.
- Japan: Alipay+ enables payment at over 3 million merchants across the country, including izakayas, wagashi shops, snack stores, guesthouses, leading retailers, health and beauty stores, and top attractions like Tokyo SKYTREE, Tokyo Solamachi and Tokyo mizumachi.
- Southeast Asia: Alipay+ is widely accepted, including via DuitNow in Malaysia and SGQR in Singapore, and local transportation options including trains in Malaysia and Thailand, and taxis in Singapore. In the Philippines, Alipay+ welcomes SM Supermalls, the largest retail chain in the Philippines and cornerstone of Filipino lifestyle culture, and Hennan Group of Resorts, a premier hospitality brand with 10 resorts in Boracay and Bohol. Users can expect special promotions at top retailers like Pavilion KL, Central Retail in Thailand, and Resorts World Sentosa in Singapore, along with nationwide vouchers for use at any local merchants accepting Alipay+.
- Europe: In popular European destinations like the United Kingdom, France, Germany, Italy and Spain, Alipay+ payment partner users can enjoy discounts at retailers, restaurants and attractions.
- Middle East: Alipay+ payment partner users will enjoy discounts at all Alipay+ merchants across the region and upsized rewards at duty-free stores in major airports in Dubai, Abu Dhabi and Istanbul.
2025 is expected to be a year of growth for the travel industry, with all regions seeing a greater number of travellers than pre-pandemic in 2019. In the Asia hotspots of Southeast Asia, Japan and South Korea, a joint report by Ant International and IDC found that tourism spending will increase more than 330% by 2027, and greater integration of payment methods across online and offline commerce will unlock even greater growth.
“Tourism is playing an increasingly significant role to local economies, accelerating growth for merchants across sectors, but businesses need to adapt to new digital habits and preferences,” said Douglas Feagin, President of Ant International. “Starting with mobile payments, Alipay+ offers merchants solutions to connect, engage and retain customers who want to leverage technology to enhance their travel experiences. We will continue to offer more innovative ways for businesses to transform and benefit from the continued growth in tourism.”
Unified solution for merchants to engage travellers from payments to digital services
Travellers can simply use their preferred home payment app, including e-wallets, banks apps and BNPL. These travellers can “travel like a local” and pay seamlessly at online and offline merchants across their travel journey from OTAs, airlines and hotels, to street-side vendors, restaurants, shopping malls, attractions, transportation and more. More than 90% of Alipay+ merchants are MSMEs so that these small businesses can grow by accepting multiple international payment apps.
Alipay+ is accepted at offline merchants in key destinations across Asia, Europe and the Middle East, covering a wide range of travel scenarios. Through its partnerships with standardised QR operators like PayPay in Japan, ZeroPay in South Korea, DuitNow in Malaysia, SGQR in Singapore and the Alipay merchant network in the Chinese mainland, users of Alipay+’s partner payment apps can make convenient payment almost everywhere in these Asian hotspots. Alipay+ continues to grow its acceptance in Europe with more than 400,000 merchants and supporting interoperable payments via Bluecode.
Via Antom, Ant International’s merchant payment and digitisation services provider, Alipay+ also connects leading Asian e-wallets to online travel platforms, most recently with AirAsia MOVE and Booking.com, simplifying the overall payments process for Asian travellers looking for a getaway this Chinese New Year and beyond.
Through A+Rewards, an in-app destination marketing platform, merchants and tourism boards can directly engage travellers, showcasing the best food, attractions and shopping in each destination, and offering exclusive promotions to attract more new customers. For example, in Singapore, through a collaboration with the Singapore Tourism Board, travellers can purchase a discounted voucher pack to use for taxis, convenience stores, shopping malls and in top attractions like Sentosa and Mandai Wildlife Reserve.
Further enhancing and streamlining the travel experience, Alipay+ offers mini programme development solutions so users of its payment partners can access a range of services, ranging from attractions booking, ride hailing and tax refunds directly within the app, saving the hassle of downloading additional apps or spending time for physical processes. Ahead of Chinese New Year, the Geneva Tourism Bureau is leveraging Alipay+’s mini program solution to launch an in-app hub on select e-wallets and banking apps to support tourists with their navigation, booking attractions, and enhancing the travel experience in Switzerland.
About Alipay+
Ant International’s Alipay+ is a suite of cross-border mobile payment and digitalisation solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250127889352/en/


Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom